Download presentation
Presentation is loading. Please wait.
Published byNathaniel Bennett Modified over 10 years ago
1
How Old is Too Old? Age, Genetics and Reproduction
Marcelle I. Cedars, M.D. Director, Division of Reproductive Endocrinology UCSF
2
What is Reproductive Aging?
Quantity: Natural process of oocyte loss Fourth month of fetal development 6-7 million Birth 1-2 million Menarche 400,000 Loss acceleration (approx. age 37) 25,000 Menopause 1000 Process: Apoptosis
4
What is Reproductive Aging?
Quality: decreased implantation potential Increase in meiotic non-disjunction “Production-line” theory Accumulated damage Deficiencies of the granulosa cells
5
Reproductive Aging: Why do we care?
Changing Demographics 20% of women wait until they are at least 35 years of age before having their first child Establishment of a career Awaiting a stable relationship Desire for financial security False sense of security provided by high-tech fertility procedures
7
Normal Biological Decline
Gougeon, Maturitas, 30: , 1998
8
Percent Increase in Birthrates
1976 1980 1985 1990 1995 35-39 30-34 40+ 15-19 25-29 20-24 CDC Vital and Health Statistics 2000
10
Concurrent Loss in Quantity AND Quality
11
Oocyte Quality Chromosomes and DNA Mitochondria and ooplasm
12
Abnormalities in oocytes increase with age
14
Impact of Genetics on Ovarian Aging
Complex Trait Genetic Familial association with age at menopause 30-85% estimates of heritability Environmental Oxidative stress Alterations in blood flow Toxins in the environment
16
Reproductive Aging Lifestyle Factors
Cigarette smoking Female Affect the follicular microenvironment Affect hormonal levels of the luteal phase Accelerates oocyte loss (menopause 1-4 years earlier) Male Negative affect on sperm production, motility and morphology Increased risk for DNA damage
17
Reproductive Aging Lifestyle Factors
Weight: BMI < 20 or > 25 Female Alterations in hormonal profile and anovulation Increased time to conception Male
18
Reproductive Aging Lifestyle Factors
Stress Lack of clear evidence Difficult to measure Some reduction with ART outcome noted Caffeine Studies with problems of recall bias Suggestion of association with reduced fertility Alcohol Biological plausibility
19
Reproductive Aging Lifestyle Factors
Environmental Factors Organic solvents Pesticides Phthalates
20
Loss of Ooctye Quality Abnormal fertilization, arrest of early development Failure to implant Post-implantation problems recognized loss developmentally delayed child (down syndrome)
21
Assessing Reproductive Age
What are you measuring? And Why? Reproductive performance Response to stimulation Live-born
22
Assessing Reproductive Age
Direct measures AFC/ovarian volume Anti-mullerian Hormone (AMH) Inhibin B Indirect measures FSH
23
Reproductive Aging Is it Quantity or Quality
FSH Indirect measure of follicular pool Decrease in inhibin B leads to increase FSH Not associated with increased risk of aneuploidy (vanMongfrans, 2004) Decreased predictive ability in populations with a low prevalence (young women)
24
Evaluation of the Ovary Testing of Ovarian Reserve
Antral follicle count Cycle day Follicle size < 3 – diminished reserve
25
Antral follicle count AFC = 18 AFC= 4
26
How to identify age-related problems?
Body as “bioassay” Shortened menstrual cycles Pre-cycle spotting
28
Ovarian Reserve Testing
Goal: To determine the functional capacity of the ovary. Specifically the quantity and quality of oocytes remaining. General Population Chance of conception Determine the time before ovarian aging begins Sub-fertile Population Chance of conception, with or without treatment Optimal dose or protocol for treatment Maheshwari, et al, 2006
29
Does Quantity = Quality?
Quantity number of oocytes retrieved Allows for selection Allows for freezing Affect on pregnancy rate/retrieval BUT does quantity = quality?? Quality Pregnancy rate Surrogate marker: Implantation rate per embryo transferred
30
Does Quantity = Quality?
Markers of ovarian reserve, such as basal AMH or FSH levels and AFCs, can predict quantity of oocytes, but are not good predictors of oocyte quality (defined as pregnancy success).
31
FSH Predicts Quantity, but not Quality
32
AFC Predicts Quantity and Quality
33
Age is the Best Predictor of Quality
IR = 28.4 PR = 28.7 IR = 15.9 p<0.001 p<0.001
34
Quantity and Quality IR Poor Responders IR P=0.78 21.6% 22.6% 38.9%
14.5% P = 0.001 P=0.78 21.6% 22.6%
35
Decreased AFC AFC Reproductive window # Follicles Age
36
Reproductive Aging Treatment
Counsel couple Likelihood for success Prepare treatment schedule Stimulation based on ovarian (not chronological ) age
38
Stimulations for Advanced Reproductive Aging
High dose protocols Flare protocols Halt protocols Antagonist protocols What’s new? Estradiol priming Minimal stimulation Androgen pretreatment
39
Estradiol Priming Goal: syncrhonize recruitment by preventing the premenstrual rise of FSH
40
Estradiol Priming addition of luteal phase GnRH antagonist
41
Minimal Stimulation Cancellation of a short treatment cycle is not a great burden.. Few oocytes is not bad at all.. Quality is more important than Quantity. Less oocytes means less burden at aspiration… Mild stimulation cycles have a higher repeat rate…
42
Minimal Stimulation
43
Minimal Stimulation Stimulation Mild: closed Conventional: open
44
Androgen Pretreatment
Role of androgens in follicular development Precursors for ovarian estrogen synthesis Augmentation of granulosa cell FSH receptor expression Stimulate IGF-I and IGF-I receptor in preantral and antral follicles Aromatase inhibitors Transdermal testosterone DHEA
45
Androgen Pretreatment
Balasch et al., 2006 Transdermal testosterone 2.5mg over 5 days
48
What to do? Early complete infertility evaluation
including testing of ovarian reserve Limit treatment recommendations to 3-4 months Improve endocrine environment/increase egg number
51
IVF – Pregnancy and Livebirth CDC 2004
52
Decide What Is Important
Having a child to raise Being pregnant Sharing genetic make-up with partner
53
Oocyte Donation Candidates Success rate
diminished ovarian reserve premature ovarian failure genetic problems Success rate 50-60%/cycle 70-90% cumulative Provides evidence that the age of the egg, NOT the uterus, is the critical factor
54
The Bottom Line Evaluate early Give a fair estimate of outcome
Develop a time-limited treatment plan
55
Thank you for your attention
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.